CNS & Neurological Disorders - Drug Targets

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders, e.g., disease-specific proteins, ...read more

  • ISSN (Print): 1871-5273
  • ISSN (Online): 1996-3181
  • Volume: 24
  • Issues: 12, 2025
2.7
5.1
Download PDF Flyer
CNS & Neurological Disorders - Drug Targets
Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Volume 24, Issue 4

Review Article
Vitamin D and Neurological Health: Unraveling Risk Factors, Disease Progression, and Treatment Potential

Pp: 245-256

Author(s): Abdullah Al Noman, Halima Afrosa, Imanul Kabir Lihu, Onusree Sarkar, Naimur Rahman Nabin, Monty Datta, Rashmi Pathak and Himanshu Sharma*

DOI: 10.2174/0118715273330972241009092828

Review Article
Proposed Hypothesis of TWEAK/Fn14 Receptor Modulation in Autism Spectrum Disorder

Pp: 257-262

Author(s): Heena Khan, Vivek Rihal, Amarjot Kaur and Thakur Gurjeet Singh*

DOI: 10.2174/0118715273330549241015073953

Review Article
Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B Inhibitors

Pp: 263-284

Author(s): Neha Rana* and Parul Grover

DOI: 10.2174/0118715273340983241018095529

Research Article
Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-loaded Solid Lipid Nanoparticles: Modulation of Cellular Signaling Pathways

Pp: 285-324

Author(s): Nitish Kumar, Nidhi Tyagi*, Sidharth Mehan and Alok Pratap Singh

DOI: 10.2174/0118715273336107241015100912